Sarah McCammon

Hundreds of Indiana doctors across specialties say a decision by the state's Medical Licensing Board to reprimand Dr. Caitlin Bernard sets a dangerous precedent about what doctors can and can't say.

Caitlin Bernard, an Indiana OB-GYN, has been under scrutiny from her state's Republican attorney general since speaking out about the impact of the Supreme Court decision overturning Roe v. Wade.

Nearly a year after the U.S. Supreme Court rolled back abortion rights, the nation's most prominent abortion provider says it will rethink its structure and cut staff.

More women who say they were put in danger by Texas' abortion bans are joining a lawsuit that seek to force the state to clarify medical exceptions in the laws.

With abortion increasingly restricted in many states, Sen. Patty Murray (D-Wash.), hopes to persuade Republicans to back insurance coverage for over-the-counter birth control.

The attorney Jonathan Mitchell is known for leveraging the law to achieve his conservative clients' goals — regardless of the potential political fallout.

New Mexico is at the heart of a fight over abortion rights that's pitting local anti-abortion ordinances against state officials who support abortion rights.

GenBioPro, which makes a generic form of mifepristone, is suing the FDA seeking to preserve access to the drug amidst ongoing federal litigation.

An administrative stay from the Supreme Court in a federal abortion pill case out of Texas expires late Wednesday, once again putting access to mifepristone in jeopardy.

With an administrative stay from the Supreme Court set to expire late Wednesday, the future of access to the abortion pill mifepristone is uncertain.

Anthony Comstock pushed Congress to crack down on what he saw as harmful vices, such as pornography and contraception. An 1873 law named for him has appeared in recent court battles over abortion.

The 19th century Comstock Act, which outlawed the distribution of "obscene" materials, including contraception, is being cited as a basis for blocking the mailing of the abortion pill mifepristone.

A U.S. appeals court ruling ratchets approval of the abortion pill mifepristone from 10 weeks of pregnancy down to seven weeks and says that — for now — the drug can no longer be sent in the mail.

The Justice Department is seeking emergency relief from the U.S. Supreme Court in a Texas case involving limited access to the abortion drug mifepristone.

The Biden administration had asked the higher court to stay a decision from a Texas judge while the appeal plays out.

A federal appeals court will allow partial access to the abortion drug mifepristone while a high-profile federal case plays out, but with new limitations on how the drug can be dispensed.

A Texas man is suing three women he says helped his ex-wife obtain an abortion "without even his knowledge." Experts say documents related to the case suggest he might have known ahead of time.

Access to mifepristone, a medication that is used in about half of all abortions nationwide, hangs in the balance of two contradictory court rulings. A date with the Supreme Court is all but certain.

California, Washington state, New York and Massachusetts are stockpiling misoprostol and mifepristone, both of which are used in abortion regimens.

A conflicting and confusing set of federal court rulings Friday is leaving abortion providers in the U.S. uncertain about the future availability of abortion pills.